Involvement of pallidal and nigral GABA mechanisms in the generation of tremulous jaw movements in rats.
Four experiments were conducted to investigate the role of pallidal and nigral GABA in the generation of tremulous jaw movements in rats. In these experiments, tremulous jaw movements were induced by i.p. injections of the anticholinesterase tacrine (5.0 mg/kg). Previous work has shown that the tremulous jaw movements induced by cholinomimetics and dopamine depletion are dependent upon striatal mechanisms. Thus, the present study investigated potential striatal output pathways that could be involved in the generation of these movements. Because there are GABAergic projections from neostriatum to entopeduncular nucleus (medial globus pallidus) and substantia nigra pars reticulata, the GABA agonist muscimol was injected directly into these structures to study the effects of GABA stimulation on tacrine-induced jaw movements. Injections of muscimol into the entopeduncular nucleus (25-100 ng) failed to have any significant effects on tacrine-induced vacuous jaw movements. However, injections of muscimol (12.5-50 ng) into the substantia nigra pars reticulata blocked the jaw movements induced by tacrine. In the third experiment, it was again demonstrated that 25.0 ng of muscimol injected directly into the substantia nigra pars reticulata blocked the jaw movements induced by tacrine; in addition, it was shown that injections of this dose 2.0 mm dorsal to the substantia nigra pars reticulata failed to affect tacrine-induced tremulous jaw movements. It was shown in the fourth experiment that injections of muscimol into a more medial portion of the substantia nigra pars reticulata also reduced tacrine-induced tremulous jaw movements. These results indicate that stimulation of GABA(A) receptors in substantia nigra pars reticulata can block tacrine-induced tremulous jaw movements. This finding is consistent with the notion that striatonigral GABA projections are involved in the generation of tremulous jaw movements. It is also possible that striatonigral GABA mechanisms are involved in human clinical phenomena such as parkinsonian tremor.
Finn
M
M
Department of Psychology, University of Connecticut, Storrs 06269-1020, USA.
Mayorga
A J
AJ
Conlan
A
A
Salamone
J D
JD
D000818:Animals; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D018755:GABA Agonists / Q000008:administration & dosage / Q000494:pharmacology; D058785:GABA-A Receptor Agonists; D005917:Globus Pallidus / Q000033:anatomy & histology / Q000378:metabolism / Q000502:physiology*; D007267:Injections; D007568:Jaw / Q000294:innervation* / Q000378:metabolism / Q000502:physiology; D008297:Male; D008845:Microinjections; D009068:Movement / Q000187:drug effects / Q000502:physiology*; D009118:Muscimol / Q000008:administration & dosage / Q000494:pharmacology; D018482:Muscle, Skeletal / Q000294:innervation* / Q000378:metabolism / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013378:Substantia Nigra / Q000033:anatomy & histology / Q000378:metabolism / Q000502:physiology*; D013619:Tacrine / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism / Q000502:physiology*
D002800:Cholinesterase Inhibitors; D018755:GABA Agonists; D058785:GABA-A Receptor Agonists; D009118:Muscimol; D013619:Tacrine; D005680:gamma-Aminobutyric Acid